Saba Capital holds 12.66% of BlackRock ECAT
Saba-related entities report a 12.66% beneficial stake in ECAT, with shared voting and dispositive power over 12.6 million common shares acquired for about $187 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock ESG Capital Allocation Term Trust (ECAT) is the subject of an amended Schedule 13D (Amendment No. 40) reporting that funds and accounts advised by Saba Capital Management, L.P. beneficially own 12,588,023 common shares, representing 12.66% of ECAT’s common shares outstanding as of June 30, 2026.
Saba Capital, Saba Capital Management GP, LLC and Boaz R. Weinstein report shared voting and dispositive power over all of these shares and no sole power. Approximately $187,126,237 was paid to acquire the reported position, funded by investor subscription proceeds, capital appreciation and ordinary-course margin borrowings. This amendment updates Items 3, 5 and 7 and incorporates recent open‑market transactions in Schedule A.
Key Figures
Key Terms
beneficial owner regulatory
margin account borrowings financial
Schedule 13D regulatory
N-CSRS regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of BlackRock ESG Capital Allocation Term Trust (ECAT) does Saba Capital report owning?
What is the source of funds for Saba’s investment in ECAT (symbol ECAT)?
What period of ECAT trading activity is referenced in this Amendment No. 40?
AI-generated analysis. How Rhea-AI works. Not financial advice.